Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems

In VitroEvaluation of the Antimicrobial Activity of Meropenem in Combination with Polymyxin B and Gatifloxacin AgainstPseudomonas aeruginosaandAcinetobacter baumannii

(2014) K.C. Guelfi et al.   JOURNAL OF CHEMOTHERAPY

The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in anIn VitroPharmacokinetic/Pharmacodynamic Model

(2012) Zakuan Z. Deris et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae

(2012) Meredith G. Jernigan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro Etest synergy of doripenem with amikacin, colistin, and levofloxacin against Pseudomonas aeruginosa with defined carbapenem resistance mechanisms as determined by the Etest method

(2012) Wendy He et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula

(2011) Phillip J. Bergen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model

(2011) Phillip J. Bergen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients

(2011) Wang Liang et al.   BMC INFECTIOUS DISEASES

Colistin pharmacokinetics: the fog is lifting

(2011) W. Couet et al.   CLINICAL MICROBIOLOGY AND INFECTION

Colistin: new lessons on an old antibiotic

(2011) D. Yahav et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU

(2011) Wang-Huei Sheng et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen

(2011) Ryan K. Shields et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae

(2011) George A. Pankey et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Clinical implications of β-lactam–aminoglycoside synergism: systematic review of randomised trials

(2011) Ronit Marcus et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates

(2011) Kyong Ran Peck et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B

(2011) Tze-Peng Lim et al.   PLoS One

In Vitro Double and Triple Bactericidal Activities of Doripenem, Polymyxin B, and Rifampin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli

(2010) C. Urban et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii

(2010) M. M. Sopirala et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii

(2010) Glenn A. Pankuch et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Effectiveness and safety of colistin: prospective comparative cohort study

(2010) Mical Paul et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae

(2010) A. Elemam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Synergistic Antimicrobial Effect of Imipenem and Colistin Against an Isolate of Multidrug-resistant Enterobacter cloacae

(2010) Kuan-Hung Lin et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones

(2010) Carlos Hernan Rodriguez et al.   Journal of Infection in Developing Countries

Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo- -Lactamase-Producing Klebsiella pneumoniae Isolates?

(2009) M. Souli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest® and time-kill assay

(2009) George A. Pankey et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index

(2009) K. E. N. Milne et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro Activities of Various Antibiotics, Alone and in Combination with Colistin Methanesulfonate, against Pseudomonas aeruginosa Strains Isolated from Cystic Fibrosis Patients

(2008) Çağla Bozkurt Güzel et al.   CHEMOTHERAPY

Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies

(2008) N. Petrosillo et al.   CLINICAL MICROBIOLOGY AND INFECTION